- Home
- ALMS vs ARCT Comparison
ALMS vs ARCT Comparison
Compare ALMS & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALMS
- ARCT
- Stock Information
- Founded
- ALMS 2021
- ARCT 2013
- Country
- ALMS United States
- ARCT United States
- Employees
- ALMS N/A
- ARCT N/A
- Industry
- ALMS
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- ALMS
- ARCT Health Care
- Exchange
- ALMS NYSE
- ARCT Nasdaq
- Market Cap
- ALMS 469.0M
- ARCT 444.5M
- IPO Year
- ALMS 2024
- ARCT N/A
- Fundamental
- Price
- ALMS $5.17
- ARCT $17.77
- Analyst Decision
- ALMS Strong Buy
- ARCT Strong Buy
- Analyst Count
- ALMS 7
- ARCT 7
- Target Price
- ALMS $28.83
- ARCT $63.60
- AVG Volume (30 Days)
- ALMS 263.6K
- ARCT 428.5K
- Earning Date
- ALMS 02-28-2025
- ARCT 03-06-2025
- Dividend Yield
- ALMS N/A
- ARCT N/A
- EPS Growth
- ALMS N/A
- ARCT N/A
- EPS
- ALMS N/A
- ARCT N/A
- Revenue
- ALMS N/A
- ARCT $160,399,000.00
- Revenue This Year
- ALMS N/A
- ARCT $6.54
- Revenue Next Year
- ALMS N/A
- ARCT $0.25
- P/E Ratio
- ALMS N/A
- ARCT N/A
- Revenue Growth
- ALMS N/A
- ARCT N/A
- 52 Week Low
- ALMS $4.74
- ARCT $14.30
- 52 Week High
- ALMS $13.53
- ARCT $45.00
- Technical
- Relative Strength Index (RSI)
- ALMS N/A
- ARCT 54.71
- Support Level
- ALMS N/A
- ARCT $16.54
- Resistance Level
- ALMS N/A
- ARCT $19.25
- Average True Range (ATR)
- ALMS 0.00
- ARCT 1.19
- MACD
- ALMS 0.00
- ARCT 0.14
- Stochastic Oscillator
- ALMS 0.00
- ARCT 62.15
About ALMS ALUMIS INC
Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.